DiaSorin SpA

Common Name
DiaSorin
Country
Italy
Sector
Healthcare
Industry
Diagnostics & Research
Employees
3,280
Ticker
DIA
Exchange
EURONEXT MILAN
Description
Diasorin S.p.A. is a global leader in the biotechnology sector, specializing in the development, production, and marketing of diagnostic tests tailored to a variety of fields. These include infectious...

DiaSorin's GHG Emissions Data Preview

In 2024, DiaSorin completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

DiaSorin has also provided a category-level breakdown for 6 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
b
0000000
Download Data

Verified Sources Behind DiaSorin’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore DiaSorin’s data sources below and access millions more through our Disclosure Search.

a. DiaSorin's Annual Report 2024
a. DiaSorin's Annual Report 2024
b. DiaSorin's Annual Report 2023
b. DiaSorin's Annual Report 2023
c. DiaSorin's Annual Report 2022
c. DiaSorin's Annual Report 2022

Insights into DiaSorin's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of DiaSorin amounted to 17,059 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of DiaSorin decreased by 9.72%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a b

DiaSorin's Scope 1 Emissions Over Time

2020202120222023202401.5 k3 k4.5 k6 ktCO2e+16%+44%-16%-10%
  • Total Scope 1
  • Year-over-Year Change

What are DiaSorin's Scope 1 emissions?

In 2024, the total Scope 1 emissions of DiaSorin were 3,513 metric tons of CO₂ equivalent (tCO₂e). a

Has DiaSorin reduced its Scope 1 emissions over time?

Since 2020, DiaSorin's Scope 1 emissions have increased by 27.24%, reflecting a rising long-term trend in Scope 1 emissions over time. a c

Compared to the previous year (2023), DiaSorin's Scope 1 emissions decreased by 9.78%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a b

What are DiaSorin's Scope 2 emissions?

In 2024, DiaSorin reported Scope 2 greenhouse gas (GHG) emissions of 12,132 tCO₂e using the market-based method and 13,546 tCO₂e using the location-based method. a

Has DiaSorin reduced its Scope 2 emissions over time?

Since 2020, DiaSorin's Scope 2 greenhouse gas (GHG) emissions ( Location-Based) have increased by 61.15%, reflecting a rising long-term trend in Scope 2 emissions over time. a c

Compared to the previous year (2023), DiaSorin's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that DiaSorin 's emissions have plateaued with no significant change in its energy consumption footprint. a b

What methodology does DiaSorin use for Scope 2 reporting?

In 2024, DiaSorin reported its Scope 2 emissions using the market-based method and using the location-based method. a

DiaSorin's Scope 2 Emissions Over Time

2020202120222023202404 k8 k12 k16 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into DiaSorin's Value Chain Emissions

In 2024, DiaSorin reported 226,256 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2024 disclosure of DiaSorin includes a breakdown across 6 of the 15 Scope 3 categories defined by the GHG Protocol, up from 0 in 2023, reflecting improved emissions accounting practices and greater transparency across the company's value chain a

DiaSorin's Scope 3 Emissions Over Time

2024060 k120 k180 k240 ktCO2e
  • Total Scope 3
  • Year-over-Year Change

What are DiaSorin's Scope 3 emissions?

In 2024, DiaSorin reported total Scope 3 emissions of 226,256 metric tons of CO₂ equivalent (tCO₂e). a

Approximately 49.96% of these emissions originated from upstream activities such as purchased goods and capital goods, while 50.04% came from downstream activities like product use, distribution, and end-of-life treatment. a

What categories of Scope 3 emissions does DiaSorin disclose?

In 2024, DiaSorin reported emissions for 6 out of the 15 Scope 3 categories defined by the GHG Protocol. a

This partial disclosure allows for some insight into the company's indirect impacts.

What are the main sources of DiaSorin's Scope 3 emissions?

In 2024, the largest contributors to DiaSorin's Scope 3 emissions were: a

  • Use of Sold Products (Cat. 11): 113,217 tCO₂e (50.04%)
  • Purchased Goods and Services (Cat. 1): 92,053 tCO₂e (40.69%)
  • Business Travel (Cat. 6): 15,306 tCO₂e (6.76%)

DiaSorin's Scope 3 Emissions by Categories

Business Travel(Cat. 6)(6.8%)Use of Sold Products(Cat. 11)(50.0%)Purchased Goods andServices (Cat. 1)(40.7%)

Insights into DiaSorin’s GHG Emissions Intensity Compared to Industry Peers

In 2024, DiaSorin reported Scope 1 greenhouse gas (GHG) emissions of 3,513 tCO₂e and total revenues of USD 1,234 millions. This translates into an emissions intensity of 2.85 tCO₂e per millions USD. a

DiaSorin's Scope 1 Emissions Intensity Compared to Peers

51002,00050,0001,000,000Scope 1 Emissions (tCO2e)505002,00020,000100,000Revenues (Millions of USD)RTHangzhou Tigermed ConsultingYear: 2024Scope 1: 210 tCO2eRevenue: $M 905Scope 1 Intensity: 0.23 tCO2e/$MVeracyteYear: 2023Scope 1: 448 tCO2eRevenue: $M 361Scope 1 Intensity: 1.24 tCO2e/$MDanaherYear: 2024Scope 1: 109,046 tCO2eRevenue: $M 23,875Scope 1 Intensity: 4.57 tCO2e/$MMettler-Toledo InternationalYear: 2024Scope 1: 27,797 tCO2eRevenue: $M 3,872Scope 1 Intensity: 7.18 tCO2e/$MJoinn Laboratories ChinaYear: 2023Scope 1: 319 tCO2eRevenue: $M 334Scope 1 Intensity: 0.96 tCO2e/$MSyngene InternationalYear: 2024Scope 1: 6,653 tCO2eRevenue: $M 404Scope 1 Intensity: 16.47 tCO2e/$MQuest DiagnosticsYear: 2021Scope 1: 238,910 tCO2eRevenue: $M 10,788Scope 1 Intensity: 22.15 tCO2e/$MQiagenYear: 2024Scope 1: 11,378 tCO2eRevenue: $M 1,978Scope 1 Intensity: 5.75 tCO2e/$MWatersYear: 2023Scope 1: 12,660 tCO2eRevenue: $M 2,956Scope 1 Intensity: 4.28 tCO2e/$MSonic HealthcareYear: 2024Scope 1: 36,098 tCO2eRevenue: $M 5,959Scope 1 Intensity: 6.06 tCO2e/$MBiomerieuxYear: 2024Scope 1: 22,000 tCO2eRevenue: $M 4,142Scope 1 Intensity: 5.31 tCO2e/$MYunkang GroupYear: 2022Scope 1: 51 tCO2eRevenue: $M 589Scope 1 Intensity: 0.09 tCO2e/$MSotera HealthYear: 2023Scope 1: 39,206 tCO2eRevenue: $M 1,049Scope 1 Intensity: 37.36 tCO2e/$MThermo Fisher ScientificYear: 2024Scope 1: 315,843 tCO2eRevenue: $M 42,879Scope 1 Intensity: 7.37 tCO2e/$MRRRevvityYear: 2023Scope 1: 2,121 tCO2eRevenue: $M 2,751Scope 1 Intensity: 0.77 tCO2e/$MTTTwist BioscienceYear: 2024Scope 1: 7 tCO2eRevenue: $M 313Scope 1 Intensity: 0.02 tCO2e/$MLumibirdYear: 2024Scope 1: 1,150 tCO2eRevenue: $M 219Scope 1 Intensity: 5.26 tCO2e/$MCharles River LaboratoriesYear: 2023Scope 1: 85,957 tCO2eRevenue: $M 4,129Scope 1 Intensity: 20.82 tCO2e/$MFleuryYear: 2023Scope 1: 7,919 tCO2eRevenue: $M 1,334Scope 1 Intensity: 5.94 tCO2e/$MIDEXX LaboratoriesYear: 2024Scope 1: 18,461 tCO2eRevenue: $M 3,898Scope 1 Intensity: 4.74 tCO2e/$MKingMed DiagnosticsYear: 2023Scope 1: 5,236 tCO2eRevenue: $M 1,202Scope 1 Intensity: 4.36 tCO2e/$MLonza GroupYear: 2024Scope 1: 319,000 tCO2eRevenue: $M 7,260Scope 1 Intensity: 43.94 tCO2e/$MDiaSorinYear: 2024Scope 1: 3,513 tCO2eRevenue: $M 1,234Scope 1 Intensity: 2.85 tCO2e/$M

How does DiaSorin's GHG emissions intensity compare to its peers?

In 2024, DiaSorin reported a Scope 1 emissions intensity of 2.85 tCO₂e per millions USD. Compared to the peer group median of 5.29 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does DiaSorin rank on GHG emissions intensity within its industry?

In 2024, DiaSorin ranked 7 out of 22 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

DiaSorin is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Insights into DiaSorin's Total Carbon Footprint

In 2024, DiaSorin reported a total carbon footprint of 243,315 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 1,187.72% increase compared to 2023, suggesting a rise in emissions across its operations or value chain. a b

The largest contributor to DiaSorin's total carbon footprint was Scope 3 emissions, accounting for 92.99% of the company's total carbon footprint, followed by Scope 2 emissions at 5.57%. a

Want Full Access to DiaSorin's GHG Emissions Dataset?
Sign Up